Overall rank by patents
#42,763
Across all tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 11 technology areas, active 2023–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: Y02E (REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION).
The verdict
Science holds 6 US patents across 11 technology areas, rank #42,763 of 50,000 tracked assignees.
Science AND Innovations—nuclear Industry Scientific Development, Private Enterprise has been granted 6 US utility patents between 2023 and 2025, placing Science AND Innovations—nuclear Industry Scientific Development, Private Enterprise at rank #42,763 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 3.8 claims per patent with primary concentration in Y02E (REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION). As a Foreign Corporation, Science AND Innovations—nuclear Industry Scientific Development, Private Enterprise is one of the more focused assignees in the PatentsView dataset. By volume, Science sits between Schneller Llc (6 patents, rank #42,759) and Scivita Medical Technology Co., Ltd. (6 patents, rank #42,767) - the closest US assignees by grant volume. The composite Innovation Score of 40.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2023 through 2025, with 6 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Science AND Innovations—nuclear Industry Scientific Development, Private Enterprise's 3.8 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Science AND Innovations—nuclear Industry Scientific Development, Private Enterprise against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
SCHNELLER LLC
6 patents
SCHOOL JUDICIAL PERSON IKUTOKU GAKUEN
6 patents
SCHOTTEL GMBH
6 patents
SCI PHARMTECH INC.
6 patents
SCIENCE CADETS, INC.
6 patents
SCIENCE RESEARCH LABORATORY, INC.
6 patents
SCIENTIFIC PROTEIN LABORATORIES, LLC
6 patents
SCIVITA MEDICAL TECHNOLOGY CO., LTD.
6 patents
SCIENCE AND INNOVATIONS—NUCLEAR INDUSTRY SCIENTIFIC DEVELOPMENT, PRIVATE ENTERPRISE
6 patents
What this shows Science holds 6 patents at rank #42,763, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #42,763 in granted patent volume.
Other assignees with the most granted patents in Science's primary technology class.
Science's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
41 Top 35% higher than 65% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2023 | 2 | 33.3% |
| 2024 | 3 | 50.0% |
| 2025 | 1 | 16.7% |
Top 11 of 11 technology areas
Overall rank by patents
#42,763
Across all tracked assignees
40.8 out of 100
How to use this portfolio
Science's 6 grants land it in the top 35% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.